New Delhi: Cipla Medpro, the South African subsidiary of the Indian firm, has received South African government's 2015-17 National ARV tender to supply AIDS treatment drugs. The deal is valued at Rs 1,100 crore.
The medication will be produced at Cipla Medpro Manufacturing (CMM), in KwaZulu-Natal. The contract is effective from 1 April, 2015 and will run for a period of three years, Cipla said in a filing to the BSE.
"Cipla is known as a pioneer of fixed dose combinations following Cipla's Dr Yusuf Hamied's accomplishment of making Aids medication available for a dollar a day in 2001," Cipla CEO Paul Miller said in a statement.
Miller said Cipla went further and made the triple combination available in the world's first 3-in-1 combination ARV.
Cipla is known as a pioneer of fixed dose combinations, following Yusuf Hamied's accomplishment of making AIDS medication available for a dollar a day in 2001.
Cipla was the third largest pharmaceutical company in South Africa.
Miller said this was the third government tender win in the last year for Cipla Medpro.
It won a R280 million state therapeutic drug tender in August and a R345m national respiratory tender in June.
